Plain-English translation of NCT05998863 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study was designed to test whether a mineral supplement called could help protect people who take acid reflux medications (like omeprazole) long-term. The medication is an effervescent powder containing calcium, magnesium, and citrate that you mix with water and drink. Researchers wanted to see if it could prevent bone loss, correct magnesium deficiency, and protect kidney function—all problems that can happen with long-term acid reflux medication use.
People who take acid reflux medications for years often develop weak bones, low magnesium levels, and kidney problems as side effects. This trial aimed to find out if adding this mineral supplement could prevent these complications and keep patients healthier over time.
This was planned as a 1-year study where participants would take either the mineral supplement or a placebo (dummy pill) mixed with water once daily. You would have regular clinic visits to have blood and urine tests, and possibly imaging scans to measure bone density and kidney function. The trial has been withdrawn and is no longer recruiting participants.
AI-generated summary from trial data · Jul 11, 2026 · Not medical advice
United States